💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for MacroGenics, Inc. (MGNX)
« Back to company indexMGNX Chatter Timeline
Stock Ticker for MGNX
Most Active Tweeters for MGNX
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @mediasentiment | 6 |
| @stockmktgenius | 3 |
| @EdgarInsider | 3 |
| @SeekingAlpha | 2 |
Recent Tweets for MGNX
 |
@Tickeron $MGNX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/g2zD5Bu6wy May 8th 2021, 7:05pm |
 |
@mediasentiment $MGNX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 956 May 7th 2021, 9:05pm |
 |
@TradingHunter2 $MGNX May21'21 30 P 894 Volume vs 426 OI 194.465 USD Volume Underlying price: 32.45 Last Option Price: 2.3 #MGNX https://t.co/uPvk81Gul2 May 7th 2021, 6:05pm |
 |
@maxm_profit RT @Tickeron: $MGNX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/xIl96EPPF7 #Ma… May 7th 2021, 7:05am |
|
@Tickeron $MGNX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/ddNVXvMPPq May 7th 2021, 3:05am |
 |
@windward_1999 @JacobPlieth @evaluatevantage Interestingly, $MGNX has HER2 drug magetixumab in GC in combination with anti-PD1 a… https://t.co/bBuEh5XaOC May 6th 2021, 4:05pm |
 |
@nolastevedore @RetroWallSt $GTBP has been ripping since April 22nd, when it was mentioned alongside $MGNX in article below. On Ap… https://t.co/5wrA5J6Laf May 6th 2021, 1:05am |
|
@mediasentiment $MGNX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 135 May 5th 2021, 9:05am |
|
@mediasentiment $MGNX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 124 May 4th 2021, 9:05am |
|
@mediasentiment $MGNX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1694 May 4th 2021, 6:05am |
|
@Tickeron $MGNX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/AZyYwKIIAu May 4th 2021, 3:05am |
 |
@MarcJacksonLA $MGNX BTIG Maintains Buy Rating On MacroGenics, $50 PT https://t.co/9weo5xSvWP May 3rd 2021, 2:05pm |
 |
@Jarvis_Alerts $MGNX [Macrogenics]: Morgan Stanley Maintains Underweight Raises Price Target $16 --> 17 https://t.co/sz3FLQHeVw May 3rd 2021, 12:05pm |
|
@mediasentiment $MGNX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 178 May 2nd 2021, 11:05am |
|
@Tickeron $MGNX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/X3JfdKDuKm May 1st 2021, 7:05pm |
 |
@EZMoney_41 $MGNX Now waiting for Buy signal https://t.co/HnyuKd0J13 April 30th 2021, 11:04pm |
 |
@Gambiste1 RT @CSIMarket: $MGNX #StockMarket #Macrogenics reported financial period ending Mar 31 2021 Results on https://t.co/savSNTKlN1: MGNX announ… April 30th 2021, 7:04pm |
 |
@CSIMarket $MGNX #StockMarket #Macrogenics reported financial period ending Mar 31 2021 Results on https://t.co/savSNTKlN1: MG… https://t.co/k0rDcWLV7z April 30th 2021, 7:04pm |
 |
@SeekingAlpha $MGNX - MacroGenics, Inc. 2021 Q1 - Results - Earnings Call Presentation. https://t.co/lgVQQ90Wae #trading #finance #business April 30th 2021, 6:04pm |
|
@Tickeron $MGNX in Uptrend: 50-day Moving Average broke above 200-day Moving Average on April 1, 2021. View odds for this and… https://t.co/oBiexfsJBl April 30th 2021, 5:04pm |
|
@mediasentiment $MGNX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 636 April 30th 2021, 5:04pm |
 |
@QuantchaIdeas Big Loser Alert: Trading today’s -7.7% move in MACROGENICS INC. COMMON STOCK $MGNX https://t.co/PXuUcpw1cE April 30th 2021, 3:04pm |
 |
@TargetPrices $MGNX Maintains SVB Leerink Outperform USD 37 » USD 40 Reiterated by HC Wainwright Buy USD 36 » USD 41 https://t.co/vHUhsERXnG April 30th 2021, 12:04pm |
 |
@MarketNFlash Morgan Stanley Maintains Underweight on Macrogenics, Raises Price Target to $17 | $MGNX April 30th 2021, 12:04pm |
|
@MarketNFlash HC Wainwright & Co. Maintains Buy on Macrogenics, Raises Price Target to $41 | $MGNX April 30th 2021, 10:04am |
 |
@newsfilterio MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results $MGNX https://t.co/qCIJr6nJvJ April 30th 2021, 8:04am |
 |
@EarningsAlley MacroGenics, Inc. $MGNX held an earnings call on 4/29/2021. Here are the highlights: April 30th 2021, 6:04am |
 |
@stockmktgenius $MGNX MacroGenics, Inc. - Commo Top stock up 433% from low. Close: 35.63 VolvsAvg: 0.78 Liq: $19M https://t.co/9ss8aG5EA5 April 30th 2021, 5:04am |
 |
@SiteFocusHQ $MGNX Earnings Intelligence Analysis of recent earnings identified MacroGenics, Inc (NASDAQ: MGNX ) business focus… https://t.co/U8EpmDcKH8 April 30th 2021, 3:04am |
|
@SeekingAlpha $MGNX - MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q1 2021 Results - Earnings Call Transcript.… https://t.co/WDWePbtrU6 April 30th 2021, 2:04am |
|
@newsfilterio MacroGenics EPS misses by $0.30, misses on revenue $MGNX https://t.co/K9USvyZGwB April 30th 2021, 2:04am |
 |
@EdgarInsider Filing for 8-K [Press/News Current Report] has been made with the SEC: $MGNX MACROGENICS INC https://t.co/rLnEESjQZy April 29th 2021, 10:04pm |
 |
@jq1234t $MGNX MGC018 4mg/kg dose had 3 melanoma patients, possible RECIST response along with RECIST response from enoblitu… https://t.co/SX7vXnoWpZ April 29th 2021, 9:04pm |
 |
@Sanctuary_Bio $MGNX $0.9M in Margenza sales, bare in mind this was launched in mid-March April 29th 2021, 8:04pm |
|
@MarcJacksonLA $MGNX MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results https://t.co/JgbpvAthOm April 29th 2021, 8:04pm |
|
@EdgarInsider A new filing Form 10-Q [Quarterly Report] has been made at the SEC by $MGNX MACROGENICS INC https://t.co/ko20UnVtbE April 29th 2021, 8:04pm |
|
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $MGNX MACROGENICS INC https://t.co/FxkAtUQQA5 April 29th 2021, 8:04pm |
 |
@kevinjaybe $MGNX Macrogenics Provides Update On Corporate Progress And First Quarter 2021 Financial Results https://t.co/gUzMMSTpOK April 29th 2021, 8:04pm |
 |
@StockTexts $MGNX MacroGenics, Inc. SEC Filing: Form 10-Q https://t.co/Bs2O4X2vX4 April 29th 2021, 8:04pm |
 |
@fintel_io $MGNX / MacroGenics files form 8-K - Financial Statements and Exhibits, Results of Operations and Financial Conditi… https://t.co/Ib6LRUDOoK April 29th 2021, 8:04pm |
|
@fintel_io $MGNX / MacroGenics files form 10-Q https://t.co/KRzgNQG6Bx April 29th 2021, 8:04pm |
 |
@stock_titan $MGNX MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results https://t.co/0RFFQ9WBzu April 29th 2021, 8:04pm |
 |
@earningsinfo $MGNX Macrogenics Inc Q1 2021 Earnings Call https://t.co/Wj2Qxnivqi April 29th 2021, 7:04pm |
 |
@StockPods $MGNX Earnings Call Today: 4:30 PM EST Webcast: https://t.co/BDKiNWHozp Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 April 29th 2021, 6:04pm |
 |
@AccesswireNews $MGNX MacroGenics, Inc. to Host Earnings Call https://t.co/3vxfpJq0sU April 29th 2021, 6:04pm |
|
@stockmktgenius $MGNX MacroGenics, Inc. - Commo Top stock up 428% from low. Close: 35.29 VolvsAvg: 0.93 Liq: $22M https://t.co/9ss8aG5EA5 April 29th 2021, 4:04am |
 |
@Jon12508683 $mgnx quietly making new high. one of the strongest bios. i remain long April 28th 2021, 7:04pm |
|
@stockmktgenius $MGNX MacroGenics, Inc. - Commo Top stock up 423% from low. Close: 34.20 VolvsAvg: 1.07 Liq: $25M https://t.co/9ss8aG5EA5 April 28th 2021, 10:04am |
 |
@LoncarFunds $CNCR holding $MGNX is scheduled to have its Q1 earnings call on Thursday, April 29 at 4:30PM ET.… https://t.co/fh05UY0dW0 April 27th 2021, 4:04pm |
 |
@startup_magnate RT $MGNX in Uptrend: 50-day Moving Average broke above 200-day Moving Average on April 1, 2021. View odds for this… https://t.co/eVcYCLcA0j April 27th 2021, 3:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
